Selected recent publications:

• Gur AS, Unal B, Zhao C, Johnson R, Edington H, Soran A.  Lobular carcinoma in situ of the breast and ductoscopy.  Breast Journal 2009 (in press)
• Unal B, Gur AS, Bhargava R, Edington H, Ahrendt G, Soran A.  Intraductal location of the sclerosing adenosis of the breast.  Bratislavske lekarske Listy.  110(4):251-2, 2009.
• Gur AS, Unal B, Edington H, Kanbour-Shakir A, Soran A.  Pseudoangiomatous stromal hyperplasia (PASH) of the breast:  Intraductal appreance.  J Obstet Gynecol Res 2009 35(4):816-8, 2009
• Wang W, Edington HD, Rao UN, Jukic DM, Wang H, Shipe-Spotloe JM, Kirkwood JM.  STAT3 as a biomarker of progression in atypical nevi of patients with melanoma dose-response effects of systemic IFN alpha therapy.  J Invest Dermatol.  2008 Aug: 128(8):1997-2002
• Wang W, Edington H, Jukic D, Rao U, Land S, Kirkwood JM.  Impact of IFN alpha 2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.  Cancer Immunol Imunother.  2008 Sep;57(9):1315-21.
• Wang W, Edington HD, Rao UN, Jukic DM, Radfar A, Wang H, Kirkwood, JM.  Effects of high-dose IFN alpha 2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3 and IL-17.  Clin Cancer Res. 2008 Dec 15:14(24):8314-20.
• Wang W, Edington HD, Rao UN, Jukic DM, Land SR, Ferrone S, Kirkwood JM.  Modulation of Signal Transducers and Activators of Transcription 1 and 3 Signaling in Melanoma by High-dose IFNalpha2b.  Clin Cancer Rs 13(5): 1523-31 March 2007
• Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D.  SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.  Oncogene 2007 26(29):4216-25
• Okada H, Lieberman FS, Walter KA, Lunsford LD, Kondziolka DS, Bejjani GK, Hamilton RL, Torres-Trejo A, Kalinski P, Cai Q, Mabold JL, Edington HD, Butterfield LH, Whiteside TL, Potter DM, Schold SC, Pollack IF.  Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.   Journal of Translational Medicine 2007.  5:67
• Yurkovetsky AR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatmaya L, Winans MT, Gorelik E, Lokshin AE.  Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha 2b.  Clinical Cancer Research 2007.  13(8):2422-8.
• DeFail, A.J., Edington H, Matthews S, Lee W-CC, Marr KG.   Controlled Release of Bioactive Doxorubicin from Microspheres Embedded with Gelatin Scaffolds.  J Biomed Mater Res 2006.  79(4):954-62
• Wankowicz-Kalinska A, Mailliard RB, Olson K, Graham E, Edington H, Kirkwood JM, Martinek S, Das PK, Storkus WJ.  Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+T cells in the lesional skin of a patient with melanoma-related depigmentation.  Melanoma Res. 2006 16(2): 165-74.
• Vallejo MC, Phelps AL, Sah N Romeo RC, Falk JS, Johnson RR, Keenan DM, Bonaventura MA, Edington HD.  Preemptive analgesia with bupivacaine for segmental mastectomy Reg Anesth Pain Med 2006, 31(3): 227-32.

CONTACT INFORMATION

Dr. Howard Edington
Phone: (412) 641-1342
Email: hedington@mail.magee.edu